Skip to main content
Clinical Trials/NCT04368364
NCT04368364
Terminated
Phase 4

A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks vs Intrathecal Morphine for Post Cesarean Section Pain

The University of Texas Health Science Center, Houston2 sites in 1 country3 target enrollmentMay 22, 2020

Overview

Phase
Phase 4
Intervention
Intrathecal morphine sulfate (ITM)
Conditions
Pain, Postoperative
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
3
Locations
2
Primary Endpoint
Total Narcotic Consumption in Morphine Equivalents (in Milligrams)
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

the purpose of this study is to compare opioid consumption in morphine equivalents between the groups that received postoperative analgesia with intrathecal morphine versus US guided QL blocks versus US guided QL catheters

Registry
clinicaltrials.gov
Start Date
May 22, 2020
End Date
June 29, 2020
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sudipta Sen

Assistant Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Elective C section via Pfannenstiel incision
  • Living singleton pregnancy
  • Gestation week at least 37 weeks
  • American Society of Anesthesiologists (ASA) status 1, 2 and 3
  • Primary and secondary C sections

Exclusion Criteria

  • Chronic pain
  • Opioid tolerant patients
  • Allergy to drugs used in the study.
  • Cognitive dysfunction
  • BMI \> 40
  • Coagulation disorder
  • Local infection
  • Inability to tolerate oral medication
  • Previous intra-abdominal surgery
  • Patients who will receive a combined spinal epidural for their C section

Arms & Interventions

Group 1 (Control group)

Intervention: Intrathecal morphine sulfate (ITM)

Group 2(Bupivacaine hydrochloride group)

Intervention: Bupivacaine hydrochloride

Group 3 (ropivacaine hydrochloride group)

Intervention: ropivacaine hydrochloride

Outcomes

Primary Outcomes

Total Narcotic Consumption in Morphine Equivalents (in Milligrams)

Time Frame: upto 72 hours post surgery

Total narcotic consumption in morphine equivalents (in milligrams) for the first 72 hours after surgery was calculated.

Secondary Outcomes

  • Total Narcotic Consumption in Morphine Equivalents (in Milligrams)(12,24,48 hours post surgery)
  • Static Pain as Measured by the Numerical Pain Score (NPS)(6, 12, 24, 48 and 72 hours post surgery)
  • Severity of Pruritus as Assessed by a Scale(24, 48 and 72 hours post surgery)
  • Severity of Nausea as Assessed by a Scale(24, 48 and 72 hours post surgery)
  • Severity of Vomiting as Assessed by a Scale(24, 48 and 72 hours post surgery)
  • Severity of Sedation as Assessed by a Scale(24, 48 and 72 hours post surgery)
  • Patient Satisfaction as Assessed by Likert Scale(72 hours post surgery)
  • Dynamic Pain as Measured by the Numerical Pain Score (NPS)(6, 12, 24, 48 and 72 hours post surgery)
  • Time to First Analgesic Request(72 hours post surgery)

Study Sites (2)

Loading locations...

Similar Trials